Effect of Benralizumab in Atopic Dermatitis

Clinical trial NCT03563066 · COMPLETED

Trial details

NCT number: NCT03563066
Sponsor: McMaster University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dermatitis, Atopic Dermatitis Eczema Skin Diseases Skin Diseases, Genetic Genetic Diseases, Inborn Skin Diseases, Eczematous Hypersensitivity Hypersensitivity, Immediate Immune System Diseases

Start date: 2018-09-04
Primary completion: 2021-09-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.